Eli Vaknin
About Eli Vaknin
Eli Vaknin serves as the Director and PFA Program Technical Lead at Biosense Webster, where he has worked since 2022. He has extensive experience in software development and team leadership, having held various roles in companies such as Elbit Systems and Intel Corporation.
Current Role at Biosense Webster
Eli Vaknin serves as the Director and PFA Program Technical Lead at Biosense Webster since 2022. In this role, he oversees a multidisciplinary R&D group, focusing on budgeting and ensuring compliance with medical device regulations. His leadership contributes to the strategic direction of the organization, particularly in the development of advanced medical technologies.
Previous Experience at Biosense Webster
Eli Vaknin has extensive experience at Biosense Webster, having held multiple positions. He worked as a Software Engineer from 2013 to 2016, followed by a role as SW Team Leader from 2016 to 2021. He then served as the System Engineering Technical Manager for 10 months in 2021 and as HTC R&D Manager for the IRE platform for 9 months in 2021-2022. His contributions included leading the development of the CARTO 3 mapping system integrated with PFA technology.
Mentorship and Talent Development
In his various roles at Biosense Webster, Eli Vaknin has been responsible for mentoring team leaders and fostering talent development within a large R&D group. His focus on leadership development has been instrumental in enhancing team capabilities and driving innovation within the organization.
Experience at Elbit Systems and Intel Corporation
Prior to his tenure at Biosense Webster, Eli Vaknin worked at Elbit Systems Ltd as a Software Team Leader from 2009 to 2012. He then transitioned to Intel Corporation, where he served as a Software Technical Leader for 11 months in 2012-2013. These roles contributed to his expertise in software development and team management.
Collaboration with Physicians
Eli Vaknin facilitates strong collaboration with physicians through 'Voice of Customers' visits and clinical case support. This engagement ensures that the development of medical technologies aligns with clinical needs and enhances the overall effectiveness of the solutions provided by Biosense Webster.